Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 782797-371-73 |
| Communication date: | 2019-04-17 |
| Posted date: | 2019-05-14 |
| Designated Public Office Holders who participated in the communication: |
Jamie Innes,
Chief of Staff
House Leader of the Liberal Party, House of Commons |
| Subject Matter of the communication: | Health, Industry, International Trade, Science and Technology |
| Communication report replaced on: | 2019-05-14 amended entry: 371-452245 |
| Responsible Officer who filed this communication report: | Pamela Fralick |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |